Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iridex (IRIX) EBT Margin (2016 - 2026)

Iridex has reported EBT Margin over the past 17 years, most recently at 33.18% for Q1 2026.

  • For Q1 2026, EBT Margin fell 2856.0% year-over-year to 33.18%; the TTM value through Jan 2026 reached 1.27%, up 161.0%, while the annual FY2026 figure was 1.27%, 161.0% up from the prior year.
  • EBT Margin for Q1 2026 was 33.18% at Iridex, up from 12.57% in the prior quarter.
  • Over five years, EBT Margin peaked at 61.74% in Q4 2024 and troughed at 29.13% in Q1 2024.
  • A 5-year average of 2.03% and a median of 13.59% in 2023 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: tumbled -2856bps in 2022 and later skyrocketed 6224bps in 2023.
  • Year by year, EBT Margin stood at 7.87% in 2022, then soared by 791bps to 54.37% in 2023, then rose by 14bps to 61.74% in 2024, then plummeted by -120bps to 12.57% in 2025, then surged by 364bps to 33.18% in 2026.
  • Business Quant data shows EBT Margin for IRIX at 33.18% in Q1 2026, 12.57% in Q3 2025, and 7.17% in Q2 2025.